Characterization of absorbable collagen sponges as recombinant human bone morphogenetic protein-2 carriers

被引:42
|
作者
Friess, W
Uludag, H
Foskett, S
Biron, R
Sargeant, C
机构
[1] Univ Erlangen Nurnberg, Dept Pharmaceut Technol, D-91058 Erlangen, Germany
[2] Univ Alberta, Dept Biomed Engn, Edmonton, AB T6G 2G3, Canada
[3] Genet Inst Inc, Andover, MA 01810 USA
关键词
collagen; bone morphogenetic protein; sterilization; crosslinking;
D O I
10.1016/S0378-5173(99)00128-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For clinical use recombinant human bone morphogenetic protein-2 (rhBMP-2) is soaked onto an absorbable collagen sponge (ACS) for bone regeneration. Therefore, loss of rhBMP-2 upon mechanical handling during implantation and a potential effect of the carrier on in vivo retention is of interest. The interactions between drug and carrier were looked at from the application mode and the amount of protein which can be mechanically expressed from the combination was investigated. The results indicated that rhBMP-2 binds to the collagen system. The most hydrophilic double extended homodimer showed the least binding affinity to ACS. By extending the waiting time between soaking and implantation, protein incorporation could be increased. In addition, the amount of rhBMP-2 which could be expressed was reduced by heavier ACS material and allowed for a shorter waiting period, especially at lower rhBMP-2 concentration. Crosslinking of ACS with formaldehyde led to reduced binding of rhBMP-2 to collagen either by direct hindrance of binding or reduction in swelling and number of binding sites available. Higher product pH or anion concentration enabled to increase rhBMP-2 incorporation but was limited by the potential precipitation of rhBMP-2. Despite a variety of chemical changes of ACS by ethylene oxide sterilization incorporation was not changed significantly. The in vivo release kinetics of I-125-rhBMP-2 from the collagen sponge were studied using a rat ectopic implant model. The ACS/rhBMP-2 systems tested demonstrated small but significant differences in the in vivo retention of rhBMP-2. Consequently, it is important to have as little variability in pH, anion concentration, crosslinking, and ACS mass as possible to achieve consistent or maximum binding and to avoid rhBMP-2 precipitation. Furthermore, these characteristics can be important for other in vivo applications. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:51 / 60
页数:10
相关论文
共 50 条
  • [1] Bone regeneration with recombinant human bone morphogenetic protein-2 (rhBMP-2) using absorbable collagen sponges (ACS): Influence of processing on ACS characteristics and formulation
    Friess, W
    Uludag, H
    Foskett, S
    Biron, R
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 1999, 4 (03) : 387 - 396
  • [2] Characterization of absorbable collagen sponges as rhBMP-2 carriers
    Friess, W
    Uludag, H
    Foskett, S
    Biron, R
    Sargeant, C
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 187 (01) : 91 - 99
  • [3] Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration
    Hollinger, JO
    Schmitt, JM
    Buck, DC
    Shannon, R
    Joh, SP
    Zegzula, HD
    Wozney, J
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1998, 43 (04): : 356 - 364
  • [4] Perioperative Complications of Recombinant Human Bone Morphogenetic Protein-2 on an Absorbable Collagen Sponge Versus Iliac Crest Bone Graft for Posterior Cervical Arthrodesis
    Crawford, Charles H., III
    Carreon, Leah Y.
    McGinnis, Mark D.
    Campbell, Mitchell J.
    Glassman, Steven D.
    SPINE, 2009, 34 (13) : 1390 - 1394
  • [5] Periodontal Regeneration Using Recombinant Human Bone Morphogenetic Protein-2 and a Bilayer Collagen Matrix
    Lee, Jungwon
    Yun, Junseob
    Kim, Kyoung-Hwa
    Koo, Ki-Tae
    Seol, Yang-Jo
    Lee, Yong-Moo
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (06) : 1602 - 1607
  • [6] A new recombinant human bone morphogenetic protein-2 carrier for bone regeneration
    Yokota, S
    Sonohara, S
    Yoshida, M
    Murai, M
    Shimokawa, S
    Fujimoto, R
    Fukushima, S
    Kokubo, S
    Nozaki, K
    Takahashi, K
    Uchida, T
    Yokohama, S
    Sonobe, T
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 223 (1-2) : 69 - 79
  • [7] Sustained release emphasizing recombinant human bone morphogenetic protein-2
    Winn, SR
    Uludag, H
    Hollinger, JO
    ADVANCED DRUG DELIVERY REVIEWS, 1998, 31 (03) : 303 - 318
  • [8] Occipitocervical fusion using recombinant human bone morphogenetic protein-2
    Shahlaie, Kiarash
    Kim, Kee D.
    SPINE, 2008, 33 (21) : 2361 - 2366
  • [9] Comparative study of recombinant human bone morphogenetic protein-2 carriers in rat subcutaneous tissues: Pilot study
    Lee, Sunkyu
    Choi, Hyunmin
    Shim, June-Sung
    Chung, Moon-Kyu
    Park, Young-Bum
    TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2015, 12 : 138 - 146
  • [10] Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects
    Rodgers, JB
    Vasconez, HC
    Wells, MD
    DeLuca, PP
    Faugere, MC
    Fink, BF
    Hamilton, D
    JOURNAL OF CRANIOFACIAL SURGERY, 1998, 9 (02) : 147 - 153